3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Prostatic Neoplasms
6
Neoplasms
5
Breast Neoplasms
3
Testicular Neoplasms
2
Polycystic Ovary Syndrome
2
Sleep Apnea, Obstructive
1
Sleep Apnea Syndromes
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Obesity
1
Neoplasm Metastasis
1
Muscle Weakness
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Metabolic Syndrome
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Infertility
1
Hypogonadism
1
Hot Flashes
1
Fatigue
1
Dyspareunia
1
Arthralgia
1
Interventions
testosterone undecanoate
3
Alendronate
2
Triptorelin Pamoate
1
Testosterone
1
Orchiectomy
1
Observation
1
Gonadotropin-Releasing Hormone
1
Clomiphene
1
Castor Oil
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hypogonadism
×
Testosterone
×
Clear all
NCT04492553
2022-11-29
Vitality
Herlev Hospital
Phase 2
Completed
7 enrolled